3月 2026
- 首頁
- Co-Diagnostics
3月 2026Co-Diagnostics的市場佔有率分析
Diagnostic solutions Learn more about our enhanced in vitro diagnostic (IVD) testing capabilities. Comprehensive tests for most qPCR equipment Choose from a range of Co-Dx’s Logix Smart® products that include RNaseP Internal Positive Control (IPC) and are compatible with most qPCR equipment. Co-Dx Logix Smart ABC Co-Dx Logix Smart COVID-19 Co-Dx Logix Smart MTB Co-Dx […]
Co-Diagnostics(包含公司地區)
查看更多網站流量與參與度資訊- co-dx.com
Co-Diagnostics的熱門網域總造訪量
了解Co-Diagnostics市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Co-Diagnostics的熱門網域平均造訪時長
分析Co-Diagnostics參與度指標。
過去 3 個月平均造訪時長
子公司細目
Co-Diagnostics的熱門網域平均頁面瀏覽量
了解Co-Diagnostics如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Co-Diagnostics
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Co-Dx, Co attended event Medical Korea 2026 on Mar 19th '26.SALT LAKE CITY, March 16, 2026 /PRNewswire/ - Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that Co-Dx will accompany World Trade Center (WTC) Utah, the Utah Governor's Office of Economic Opportunity (GOEO), BioUtah, and other legislative and industry leaders at Medical Korea 2026, taking place March 19-22 in Seoul, South Korea.
3月 16, 2026閱讀更多
新聞Co-Dx, Co attended event The Union World Conference on Nov 20th '25.Co-Diagnostics (Nasdaq: CODX) addressed tuberculosis testing adoption at The Union World Conference on Lung Health on Nov 20, 2025 in Copenhagen.
11月 20, 2025閱讀更多
新聞Co-Dx, Co received financing of $7M in registered direct offering on Oct 29th '25.Co-Diagnostics, Inc. announces closing of $7.0 million registered direct offering of common stock priced at-the-market under nasdaq rules.
10月 29, 2025閱讀更多
查看所有Co-Diagnostics信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
